Pfizer Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on January 30, 2017, inter alia, to consider and take on record the Unaudited Financial Results of the Company for the third quarter and nine months ended December 31, 2016 (Q3).
Further, the Trading Window for trading in the Equity shares of the Company will be closed from January 20, 2017 to February 01, 2017, both days inclusive.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
